DE602006006870D1 - FEXOFENADINLÖSUNGSFORMULIERUNG - Google Patents

FEXOFENADINLÖSUNGSFORMULIERUNG

Info

Publication number
DE602006006870D1
DE602006006870D1 DE602006006870T DE602006006870T DE602006006870D1 DE 602006006870 D1 DE602006006870 D1 DE 602006006870D1 DE 602006006870 T DE602006006870 T DE 602006006870T DE 602006006870 T DE602006006870 T DE 602006006870T DE 602006006870 D1 DE602006006870 D1 DE 602006006870D1
Authority
DE
Germany
Prior art keywords
fexofenadinlösungsformulierung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006006870T
Other languages
German (de)
Inventor
Prafulla Agrawala
Kazimierz Chrzan
Rajiv Haribhakti
Matthew Mermey
Curtis J Porcello
Gary Lee Silvey
Vinh Tran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis US LLC
Original Assignee
Sanofi Aventis US LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38120312&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006006870(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis US LLC filed Critical Sanofi Aventis US LLC
Publication of DE602006006870D1 publication Critical patent/DE602006006870D1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
DE602006006870T 2005-12-14 2006-12-12 FEXOFENADINLÖSUNGSFORMULIERUNG Active DE602006006870D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75030305P 2005-12-14 2005-12-14
PCT/US2006/047393 WO2007070517A2 (en) 2005-12-14 2006-12-12 Fexofenadine suspension formulation

Publications (1)

Publication Number Publication Date
DE602006006870D1 true DE602006006870D1 (en) 2009-06-25

Family

ID=38120312

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006006870T Active DE602006006870D1 (en) 2005-12-14 2006-12-12 FEXOFENADINLÖSUNGSFORMULIERUNG

Country Status (39)

Country Link
US (1) US8933097B2 (en)
EP (1) EP1965768B1 (en)
JP (1) JP5308824B2 (en)
KR (1) KR101452792B1 (en)
CN (1) CN101316580B (en)
AR (1) AR058323A1 (en)
AT (1) ATE431137T1 (en)
AU (1) AU2006326551B2 (en)
BR (1) BRPI0619895B1 (en)
CA (1) CA2633086C (en)
CR (1) CR9993A (en)
CY (1) CY1109320T1 (en)
DE (1) DE602006006870D1 (en)
DK (1) DK1965768T3 (en)
DO (1) DOP2006000274A (en)
EC (1) ECSP088532A (en)
EG (1) EG25866A (en)
ES (1) ES2327168T3 (en)
HK (1) HK1123197A1 (en)
HN (1) HN2008000875A (en)
HR (1) HRP20090411T1 (en)
IL (1) IL192067A (en)
JO (1) JO2549B1 (en)
MA (1) MA30152B1 (en)
MY (1) MY146988A (en)
NO (1) NO339877B1 (en)
NZ (1) NZ568943A (en)
PE (1) PE20071003A1 (en)
PL (1) PL1965768T3 (en)
PT (1) PT1965768E (en)
RS (1) RS51135B (en)
RU (1) RU2405538C2 (en)
SI (1) SI1965768T1 (en)
TN (1) TNSN08186A1 (en)
TW (1) TWI377061B (en)
UA (1) UA89584C2 (en)
UY (1) UY30021A1 (en)
WO (1) WO2007070517A2 (en)
ZA (1) ZA200803985B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101546774B1 (en) 2008-07-29 2015-08-24 엘지전자 주식회사 Mobile terminal and operation control method thereof
WO2013058996A1 (en) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
US10130620B2 (en) 2013-07-01 2018-11-20 Aventisub Llc Liquid pharmaceutical composition for oral administration comprising fexofenadine
AU2014284294A1 (en) * 2013-07-03 2016-01-21 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
CN103610645B (en) * 2013-11-25 2016-05-11 浙江万晟药业有限公司 A kind of pharmaceutical composition of fexofenadine hydrochloride and preparation method
CN106806346B (en) * 2015-12-01 2020-09-11 国药集团广东环球制药有限公司 Fexofenadine hydrochloride dry suspension preparation and preparation method thereof
WO2017218894A1 (en) 2016-06-16 2017-12-21 Cutispharma, Inc. Composition and method for proton pump inhibitor suspension
KR102642434B1 (en) 2017-06-02 2024-02-29 테이카 세이야쿠 가부시키가이샤 Slightly water-soluble ingredient solubilized micelles and liquid preparations containing them
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension
WO2022175829A1 (en) 2021-02-17 2022-08-25 Cellix Bio Private Limited Topical formulations and compositions
CN115715759B (en) * 2022-11-03 2024-01-12 京海盛达(北京)科技有限公司 Antihistamine suspension and preparation method thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
CN1148849A (en) 1994-05-18 1997-04-30 赫彻斯特马里恩鲁斯公司 Process for preparing anhydrous and hydrate forms of antihistaminic pipeeridine derivatives, polymorphs and spseudormophs thereof
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
GB9822170D0 (en) 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
ES2301662T3 (en) 2001-07-31 2008-07-01 Texcontor Etablissement PHEXOPHENADINE CHLORHYDRATE POLYMORPH
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
EP1587496B1 (en) * 2003-01-30 2009-10-07 Ethypharm Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
EP2486942B1 (en) * 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20090149508A1 (en) 2005-07-27 2009-06-11 Sandoz Ag Process for the preparation of substituted phenyl ether compounds
BRPI0614231A2 (en) * 2005-08-05 2012-12-11 Lupin Ltd fexofenadine pharmaceutical compositions in oral suspension form

Also Published As

Publication number Publication date
TWI377061B (en) 2012-11-21
US20080299211A1 (en) 2008-12-04
WO2007070517A2 (en) 2007-06-21
MY146988A (en) 2012-10-15
DOP2006000274A (en) 2007-10-15
HN2008000875A (en) 2012-01-30
NZ568943A (en) 2010-04-30
WO2007070517A3 (en) 2007-08-23
CA2633086A1 (en) 2007-06-21
ATE431137T1 (en) 2009-05-15
KR20080074180A (en) 2008-08-12
EP1965768B1 (en) 2009-05-13
CY1109320T1 (en) 2014-07-02
ZA200803985B (en) 2009-03-25
IL192067A (en) 2010-12-30
PE20071003A1 (en) 2007-10-03
ECSP088532A (en) 2008-08-29
PT1965768E (en) 2009-08-07
NO339877B1 (en) 2017-02-13
RU2405538C2 (en) 2010-12-10
BRPI0619895B1 (en) 2022-04-12
JP5308824B2 (en) 2013-10-09
CA2633086C (en) 2011-10-18
IL192067A0 (en) 2009-02-11
CR9993A (en) 2008-09-23
UY30021A1 (en) 2007-07-31
NO20082904L (en) 2008-09-10
KR101452792B1 (en) 2014-10-22
JP2009519935A (en) 2009-05-21
EP1965768A2 (en) 2008-09-10
RU2008128418A (en) 2010-01-20
AR058323A1 (en) 2008-01-30
UA89584C2 (en) 2010-02-10
BRPI0619895A2 (en) 2011-10-25
TNSN08186A1 (en) 2009-10-30
HK1123197A1 (en) 2009-06-12
RS51135B (en) 2010-10-31
TW200812581A (en) 2008-03-16
EG25866A (en) 2012-09-12
HRP20090411T1 (en) 2010-01-31
US8933097B2 (en) 2015-01-13
JO2549B1 (en) 2010-09-05
CN101316580A (en) 2008-12-03
PL1965768T3 (en) 2009-11-30
SI1965768T1 (en) 2009-10-31
ES2327168T3 (en) 2009-10-26
CN101316580B (en) 2011-11-16
AU2006326551A1 (en) 2007-06-21
DK1965768T3 (en) 2009-09-07
MA30152B1 (en) 2009-01-02
AU2006326551B2 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
ATE408603T1 (en) PYRAZOLYLCARBOXANILIDES
DE602005020856D1 (en) UNTERHOSE
CR9974A (en) GAVIÓN
DE602006000103D1 (en) Ansaugtraktanordnung
DE602006000345D1 (en) Scheibenbremsaktuator
DE502006003394D1 (en) LEHNENKLAPPUNG
DE602005011440D1 (en) Höhenmessuhr
DE602006000257D1 (en) Elektronenstrahlsterilisator
DE502006008475D1 (en) WASSERPUMPENFLÜGELRAD
DE502006005667D1 (en) GELENKLAGER
ATE549324T1 (en) TETRAHYDROBENZOXAZINE
DE502006005768D1 (en) Hydrolysestabilisatorformulierungen
DK1965768T3 (en) Fexofenadine-opläsningsformulering
DE602005009179D1 (en) Telekommunikatiosverbinder
DE602006000139D1 (en) Biderzeugungsvorrichtung
DE112006002964A5 (en) Zweirichtungsreflektanzverteilungsmessgerät
DE502005005839D1 (en) FELDGEERÄT
DE602005021060D1 (en) Notrufleitweglenkung
DE502006001397D1 (en) LAGERBUCHSE
DE602005023501D1 (en) Radhausbau
DE602005003547D1 (en) Fahrradantriebsnabe
ATE485368T1 (en) HIV - VACCINATION
DE502006004302D1 (en) VERSCHLUSSKAPPE
DE502006001004D1 (en) hydromount
DE102005052834B8 (en) Punktschweißklebverbindung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition